|
|
|
|
| Symbol(s): |
PTIE |
| Date: |
7-Feb-10 |
| Contributor: |
PriceTarget Research, Inc. |
| Title: |
Pain Therapeutics has a current Overall Rating of D (Negative). |
| Document Size: |
7 pages |
| Price: |
$25 |
| Document Type: |
Adobe Acrobat Reader®
Download free Adobe Acrobat Reader® |
|
| Research Reports Premium Services |
| ·
|
Get the full report for $25. |
| ·
|
You will have access to this report for 24 hours. |
|
|
|
|
|
| Pain Therapeutics has a current Overall Rating of D (Negative). Power Rating (27) is low; appreciation potential (13) is negative. Relative to the S&P 500 Composite, Pain Therapeutics Inc has moderate Value characteristics -- its appeal is likely to be to Capital Gain-oriented investors. PTIE is of high investment quality. Pain Therapeutics' current technical position is very strong. Pain Therapeutics' Power Rating is 27. PTIE's earnings estimates have fallen very significantly in...
| | |
|
|
